CONCORDBIO - Technical Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Technical Rating: 3.9

Here's a breakdown of Concord Biotech’s technical setup and short-term trading outlook

📉 Trend Assessment

Current Price: ₹1,833 — just above 50 DMA (₹1,825) and 200 DMA (₹1,795)

Trend Status: Slight uptrend continuation with emerging signs of consolidation

Support Zone: ₹1,775–₹1,800

Resistance Zone: ₹1,950–₹2,000

The stock’s long-term uptrend appears intact but is now in a cooling phase with reduced volume and near-neutral momentum.

🔄 Momentum Indicators

RSI: 47.3 – Neutral, suggesting no strong momentum

MACD: 16.4 – Positive, with a bullish signal; indicates potential for short-term upside if volume returns

Volume: 80,064 vs avg of 1,21,014 – Volume has declined, meaning less trader conviction

Together, MACD suggests bullish bias, but RSI and weak volume imply hesitation.

📊 Moving Averages

Indicator Value (₹) Commentary

50 DMA 1,825 Just crossed above it, mildly bullish

200 DMA 1,795 Far from support, strong foundation

Both averages support a bullish tone, but close range between them highlights consolidation.

📎 Bollinger Bands

While exact band levels aren’t provided

Price near mid-band, in tightening range

Indicates low volatility and sideways movement

This generally precedes a breakout or breakdown.

📍 Trading Zones

Type Range (₹) Strategy

Buy Zone 1,790–1,820 Near 200 DMA + long-term support

Target Zone 1,950–2,000 Short-term breakout levels

Exit Zone Above 2,050 Secure profits if breakout holds

📌 Technical Signals Summary

Trend: Mild uptrend but now consolidating

Momentum: Mixed; MACD bullish but RSI neutral and volume weak

Entry Opportunity: Near ₹1,800–₹1,825 if price pulls back

Risk: FII and DII both have trimmed positions, signaling caution

🧭 Bottom Line

Concord Biotech is technically sound but seems to be digesting its recent gains. A breakout above ₹1,950–₹2,000 backed by strong volume would confirm trend continuation. Until then, watch for dips near ₹1,800 as accumulation zones.

Want a quick visual chart sketch or deeper dive into its valuation metrics? I’ve got you covered.

Edit in a page